Prelude Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Sell |
64,584
-76,918
| -54% | -$127K | 0.01% | 904 |
|
|
2025
Q1 | $224K | Buy |
141,502
+82,102
| +138% | +$130K | 0.02% | 782 |
|
|
2024
Q4 | $199K | Sell |
59,400
-5,747
| -9% | -$19.3K | 0.01% | 871 |
|
|
2024
Q3 | $122K | Buy |
65,147
+113
| +0.2% | +$212 | 0.01% | 1034 |
|
|
2024
Q2 | $128K | Sell |
65,034
-29,566
| -31% | -$58.2K | 0.01% | 980 |
|
|
2024
Q1 | $290K | Sell |
94,600
-23,500
| -20% | -$72.1K | 0.02% | 820 |
|
|
2023
Q4 | $275K | Buy |
+118,100
| New | +$275K | 0.02% | 668 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$1K | – | 1772 |
|
|
2018
Q3 | $1K | Sell |
1
-27
| -96% | -$27K | ﹤0.01% | 1321 |
|
|
2018
Q2 | $16K | Buy |
+28
| New | +$16K | ﹤0.01% | 1117 |
|